
Jiangsu Maysta Chemical Co., Ltd.
SSE:603041.SS
11.25 (CNY) • At close May 7, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue
| 601.171 | 501.006 | 496.787 | 494.956 | 389.549 | 338.597 | 305.166 | 301.253 | 282.226 | 268.927 | 292.05 | 278.533 | 258.305 |
Cost of Revenue
| 427.317 | 308.919 | 359.697 | 376.652 | 240.484 | 204.616 | 225.006 | 199.059 | 163.441 | 157.298 | 179.739 | 168.39 | 155.835 |
Gross Profit
| 173.853 | 192.087 | 137.091 | 118.304 | 149.065 | 133.981 | 80.16 | 102.194 | 118.785 | 111.63 | 112.312 | 110.143 | 102.471 |
Gross Profit Ratio
| 0.289 | 0.383 | 0.276 | 0.239 | 0.383 | 0.396 | 0.263 | 0.339 | 0.421 | 0.415 | 0.385 | 0.395 | 0.397 |
Reseach & Development Expenses
| 35.903 | 29.621 | 25.955 | 22.174 | 20.94 | 21.244 | 21.781 | 18.677 | 15.248 | 12.895 | 10.953 | 10.846 | 9.612 |
General & Administrative Expenses
| 8.873 | 9.792 | 5.308 | 4.491 | 6.362 | 6.788 | 4.817 | 6.391 | 3.181 | 3.949 | 3.448 | 19.281 | 16.629 |
Selling & Marketing Expenses
| 9.331 | 11.652 | 21.187 | 15.283 | 17.56 | 24.144 | 14.525 | 15.804 | 13.116 | 11.104 | 14.329 | 11.79 | 11.744 |
SG&A
| 18.203 | 21.444 | 26.495 | 19.774 | 23.922 | 30.932 | 19.342 | 22.195 | 16.297 | 15.053 | 17.776 | 31.072 | 28.373 |
Other Expenses
| 43.241 | 12.634 | 14.19 | 15.005 | 12.914 | 13.253 | -0.01 | -0.002 | 1.708 | 3.34 | 0.709 | 0.552 | -0.084 |
Operating Expenses
| 97.348 | 63.698 | 66.64 | 56.954 | 57.776 | 65.428 | 51.394 | 50.427 | 43.633 | 40.323 | 37.136 | 33.275 | 30.503 |
Operating Income
| 76.506 | 128.388 | 89.454 | 71.347 | 120.142 | 83.512 | 45.461 | 57.999 | 78.9 | 73.826 | 79.139 | 75.991 | 73.293 |
Operating Income Ratio
| 0.127 | 0.256 | 0.18 | 0.144 | 0.308 | 0.247 | 0.149 | 0.193 | 0.28 | 0.275 | 0.271 | 0.273 | 0.284 |
Total Other Income Expenses Net
| 0.135 | 0.433 | 0.012 | 0.113 | 8.889 | -0.002 | -0.01 | -0.002 | 1.707 | 3.338 | 0.706 | 0.549 | 1.22 |
Income Before Tax
| 76.641 | 128.821 | 89.466 | 71.46 | 129.031 | 83.51 | 45.451 | 57.997 | 80.607 | 77.164 | 79.845 | 76.54 | 73.188 |
Income Before Tax Ratio
| 0.127 | 0.257 | 0.18 | 0.144 | 0.331 | 0.247 | 0.149 | 0.193 | 0.286 | 0.287 | 0.273 | 0.275 | 0.283 |
Income Tax Expense
| 18.215 | 18.996 | 10.548 | 7.658 | 18.069 | 11.469 | 4.627 | 7.422 | 12.349 | 9.823 | 11.328 | 11.118 | 10.732 |
Net Income
| 64.142 | 109.997 | 78.931 | 63.816 | 110.966 | 72.041 | 40.824 | 50.574 | 68.258 | 67.34 | 68.517 | 65.422 | 62.456 |
Net Income Ratio
| 0.107 | 0.22 | 0.159 | 0.129 | 0.285 | 0.213 | 0.134 | 0.168 | 0.242 | 0.25 | 0.235 | 0.235 | 0.242 |
EPS
| 0.35 | 0.61 | 0.44 | 0.45 | 0.79 | 0.51 | 0.29 | 0.39 | 0.65 | 0.64 | 0.65 | 0.62 | 0.59 |
EPS Diluted
| 0.35 | 0.61 | 0.44 | 0.45 | 0.79 | 0.51 | 0.29 | 0.39 | 0.65 | 0.64 | 0.65 | 0.62 | 0.59 |
EBITDA
| 134.061 | 148.851 | 107.974 | 89.001 | 146.134 | 99.282 | 59.515 | 72.495 | 94.319 | 87.939 | 82.911 | 79.122 | 71.967 |
EBITDA Ratio
| 0.223 | 0.297 | 0.217 | 0.18 | 0.375 | 0.293 | 0.195 | 0.241 | 0.334 | 0.327 | 0.284 | 0.284 | 0.279 |